Eloxx Pharmaceuticals (ELOX) Financial Statements

289 Followers

Eloxx Pharmaceuticals Financial Overview

Eloxx Pharmaceuticals's market cap is currently $504.09K. The company's EPS TTM is $; its P/E ratio is -2.06; Eloxx Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 23	Mar 22	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -695.00K	$ -960.00K	$ -571.00K	$ -559.00K
Operating Income	$ -6.44M	$ -34.42M	$ -42.35M	$ -29.44M	$ -50.55M
EBITDA	$ -4.95M	$ -33.50M	$ -64.51M	$ -28.87M	$ -50.00M
Net Income	$ -6.00M	$ -36.06M	$ -66.73M	$ -34.58M	$ -50.87M
Balance Sheet
Cash & Short-Term Investments	$ 4.79M	$ 19.47M	$ 42.57M	$ 24.72M	$ 56.32M
Total Assets	$ 5.27M	$ 21.12M	$ 45.14M	$ 26.48M	$ 58.95M
Total Debt	$ 1.00M	$ 13.38M	$ 13.46M	$ 12.04M	$ 15.76M
Net Debt	$ -3.79M	$ -6.08M	$ -29.11M	$ -12.69M	$ -6.77M
Total Liabilities	$ 17.18M	$ 31.78M	$ 22.75M	$ 16.25M	$ 22.73M
Stockholders' Equity	$ -11.91M	$ -10.66M	$ 22.38M	$ 10.23M	$ 36.21M
Cash Flow
Free Cash Flow	$ 0.00	$ -31.91M	$ -35.09M	$ -28.17M	$ -39.43M
Operating Cash Flow	$ -6.33M	$ -31.84M	$ -35.00M	$ -28.17M	$ -39.39M
Investing Cash Flow	$ 1.00K	$ -66.00K	$ 2.06M	$ 33.79M	$ -33.52M
Financing Cash Flow	$ 11.00M	$ 8.81M	$ 50.79M	$ -3.44M	$ 46.80M

Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Income Statement >

Eloxx Pharmaceuticals Debt to Assets

Balance Sheet >

Eloxx Pharmaceuticals Cash Flow

Cash Flow >

Eloxx Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >